Synergy Pharmaceuticals, Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Citeline's Biomedtracker. Lotus Licenses Corium’s Alzh

Gilead Sciences, Inc. turned to the National Advertising Division rather than the US Food and Drug Administration when it sought action against ViiV Healthcare ’s Dovato HIV drug advertising claims.

The US Food and Drug Administration got right back into the novel drug approval game after a week off, giving its go-ahead to Ardelyx Inc. 's Ibsrela (tenapanor) for the treatment of irritable bowel

Ardelyx Inc. ’s first drug approval makes it a commercial-stage company, but the cardiorenal disease-focused firm has no intention of marketing Ibsrela on its own for constipation-predominant irritabl